Please enable Javascript
The HemOnc Pulse
Meeting News
The HemOnc Pulse Live
Video Insights
In Print
Subscribe
Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Lymphoma
Aggressive B-Cell Lymphoma
Hodgkin Lymphoma
Indolent B-Cell Lymphoma
Mantle Cell Lymphoma
T-Cell Lymphoma
MPN
Myelofibrosis
Polycythemia Vera
MDS
Myeloma
Transplantation & Cellular Therapy
Heme Today
Menu
Sara Karlovitch
Sara Karlovitch is a freelance journalist who covers business, health care, and life sciences.
Articles by Sara Karlovitch
More Than Half a Million in Funding Granted to Study the Impact of RAS Mutations in AML
Sara Karlovitch
Acute Myeloid Leukemia
|
August 26, 2025
A UC researcher secures $500K+ in grants to explore RAS inhibitors as potential treatments for acute myeloid leukemia.
Read More
As Measles Cases Reach a Record High, Oncologists Feel the Impact
Sara Karlovitch
Print
|
August 8, 2025
Measles cases are the highest in 33 years, with more than 1,000 cases reported in 2025 as of July.
Read More
Glofitamab Shows Staying Power When Paired With R-CHOP or Pola-R-CHP in LBCL
Sara Karlovitch
Aggressive B-Cell Lymphoma
|
August 4, 2025
Glofitamab combos show high, durable responses in high-risk LBCL, per phase II COALITION trial in younger patients.
Read More
FDA Plans to Use AI to Streamline Approval Processes
Sara Karlovitch
Uncategorized
|
July 29, 2025
FDA roadmap explores AI to predict toxicity, cut animal testing, and speed drug development with chip tech.
Read More